- Home
- CNXN vs ELVN Comparison
CNXN vs ELVN Comparison
Compare CNXN & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNXN | ELVN |
|---|---|---|
| Founded | 1982 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 2.3B |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CNXN | ELVN |
|---|---|---|
| Price | $63.24 | $43.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $43.40 |
| AVG Volume (30 Days) | 51.1K | ★ 1.6M |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.25% | N/A |
| EPS Growth | N/A | ★ 3.17 |
| EPS | ★ 3.27 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.24 | N/A |
| Revenue Next Year | $4.39 | N/A |
| P/E Ratio | $19.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $54.97 | $14.79 |
| 52 Week High | $71.17 | $46.31 |
Technical Indicators
Market Signals| Indicator | CNXN | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 61.43 | 67.89 |
| Support Level | $61.71 | $18.04 |
| Resistance Level | $65.39 | N/A |
| Average True Range (ATR) | 1.66 | 2.71 |
| MACD | 0.61 | 0.41 |
| Stochastic Oscillator | 77.56 | 76.38 |
Price Performance
Historical ComparisonAbout CNXN PC Connection Inc.
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.